Overall aim Improving the access to and the quality of health and social services for marginalised people

Size: px
Start display at page:

Download "Overall aim Improving the access to and the quality of health and social services for marginalised people"

Transcription

1 Overall aim Improving the access to and the quality of health and social services for marginalised people To tackle health inequalities and to improve prevention, care and treatment services, targeting blood-borne infectious diseases (BBID s), in particular Hepatitis C and HIV/AIDS among vulnerable and high risk populations

2 Why? Acces to health services is limited Quality of services is not sufficiant Policies are not targeted Health problems of marginalised groups and people are a threat for public health and welfare!

3 How? Creating a platform for mutual exchange Collecting and reviewing existing evidence Implementing innovative approaches Addressing the policy level: Translation of outcomes and results towards the policy level

4

5

6

7 DPIP project 2013/14

8

9 Partner 30 partner from 15 countries 08 universities / health institutes 15 service provider (NGO's) 02 drug user organisations 05 European Networks Observer: EMCDDA, ECDC, WHO

10

11 Aims improve knowledge improve capacities Influence policies

12 Working streams WS 0 Coordination FRG WS 1 Evaluation CIAR WS 2 Inventory CIAR WS 3 Peer training SDUU WS 4 Literature review CHIP WS 5 Policy & Advocacy APDES

13

14

15 Liver or Die To inform and to be informed To learn and to teach Ett projekt som drivs av Svenska Brukarföreningen, med stöd av Smittskyddsinstitutet

16

17 Feedback hard to access young drug user lack of competence of health care professionals to communicate with patients test kits not available wrong information: cut and paste from HIV info - great need of hep c support groups - systemic barriers: opening/appointment hours no services on the country side fear of side effects no information or only negative ones waiting lists for access active drug user are not treated, alcohol sober for 2 years

18 Workstream 2 Inventory of effective interventions Rationale * Testing for HCV and referral to HCV treatment are key interventions * In practice testing rates are low, except from substitution treatment * PWUD are often not aware about risk of HCV infection * Low-threshold services assume that most PWUD are tested in prison THUS HCV testing needs to be increased in particular in low-threshold services

19 Guidelines Compilation of the most recent guidelines for HCV testing and antiviral treatment Aim Guidelines as indicators for assessment and evaluation of good practice in HCV testing, pre- and post-test counselling and referral to treatment services Delivered to active drug users

20 Interviews drug users Interviews with 50 clients of the low-threshold drug services Method: Structured questionnaire Access: through services that participate in the monitoring Topics: risk awareness and risk behaviour previous HCV testing willingness to uptake HCV testing experiences with pre- and post-test counselling acceptance of HCV treatment

21 Interviews staff In services which implemented the monitoring tool Qualitative face-to-face interviews Objective > To identify possibles barrierrs barriers to testing and referral to treatment at different levels > Structure - limited staff > Economic limited funding for testing > Individual clients not want to get tested

22 Results Study results and toolkit Toolkit with templates 4 national events: Portugal, Finland, Germany, Romania

23 Results resource centre peer training manual policy & advocacy strategy Literature review Study results and toolkit

24 Workstream Policy Activities: 1. Mapping, analyzing and comparing existing national and European Hepatitis C action plans, strategies, recommendations and guidelines. 2. Development and implementation of 1 European and 4 national advocacy strategies. 3. Organising 1 European Parliamentary meeting and 4 national policy dialogue meetings. 4. Setting up a sustainable Hepatitis C and drug use platform of experts and stakeholders.

25 Next year Facebook campaign Hepatitis policy event EP, autumn 2014 final conference Berlin, October 2014

26 Get involved!

From Research to Practice Examples from European projects

From Research to Practice Examples from European projects From Research to Practice Examples from European projects Eberhard Schatz Project Coordinator > European network since 2004 > Access to health and social services for marginalised groups > Financed 2004

More information

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups

The Imp.Ac.T.project. Improving Access to HIV/TB Testing for marginalized groups The Imp.Ac.T.project Improving Access to HIV/TB Testing for marginalized groups Presentation at DRID meeting EMCDDA 11 Oct. 2012 -Jenneke van Ditzhuijzen Acknowledgments: The Project Imp.Ac.T. Improving

More information

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen

NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Expert Group on HIV/AIDS and Associated Infections Progress report 27 October, 2011 Chair Dr. Ali Arsalo and ITA Ms Outi Karvonen NDPHS Goals for the HIV/AIDS & AI Expert Group Goal 2: Prevention

More information

HIV/AIDS, STI, hepatitis

HIV/AIDS, STI, hepatitis ECDC update HIV/AIDS, STI, hepatitis HIV EU Think Tank meeting Brussels, 25-26 March 2009 European Centre for Disease Prevention and Control HIV and AIDS surveillance activities Coordination of European-wide

More information

Hepatitis C Strategy. About us. What is hepatitis C?

Hepatitis C Strategy. About us. What is hepatitis C? Hepatitis C Strategy About us We support people to take control of their lives and make positive changes. For fifty years we have made a difference to people who want to change their relationship with

More information

HIV, HBV and HCV testing policy experiences and lessons learned.

HIV, HBV and HCV testing policy experiences and lessons learned. HIV, HBV and HCV testing policy experiences and lessons learned. Contents HIV and viral hepatitis: distinct epidemics at different stages of evolution Epidemiology: transmission, prevalence, incidence

More information

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014

Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Feedback from joint country mission on HIV and hepatitis B and C of ECDC and EMCDDA experts to Latvia, September 2014 Dr. Nicole Werner-Keišs Lisbon, 16.10.2014 Outline Background, scope and objectives

More information

Table Of Content. Outputs... 8

Table Of Content. Outputs... 8 Table Of Content Expanding Network for Coordinated and Comprehensive Actions on HIV/AIDS Prevention among IDUs and Bridging Population... 2 Summary... 3 Coordinator, Leader contact and partners... 6 Tervise

More information

SUMMARY OF INTERIM REPORT

SUMMARY OF INTERIM REPORT EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL EXECUTIVE AGENCY FOR HEALTH AND CONSUMERS Health unit SUMMARY OF INTERIM REPORT Title: Empowering Civil Society and Public Health System to

More information

Drug Use, Harm Reduction, and HIP

Drug Use, Harm Reduction, and HIP Drug Use, Harm Reduction, and HIP Strategies for Engaging PWIDs in HIV Prevention Services Presented by: Katie Burk, MPH Narelle Ellendon, RN Harm Reduction Coalition Founded in 1993 by needle exchange

More information

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer

Integrated harm reduction services for drug users and homeless people. Katrin Schiffer Integrated harm reduction services for drug users and homeless people Katrin Schiffer Content Introduction Presentation of Correlation Network Harm Reduction in a nutshell basic principles and critical

More information

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement

Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Best Prac*ces Model for Harm Reduc*on in Bri*sh Columbia: Community Involvement Authors: Despina Tzemis, Lianping Ti, Margot Kuo, Jennifer Campbell, Jane Buxton and the HRSS CommiAee Harm Reduc*on Program

More information

Assessment of HIV Knowledge, Attitude and Behaviour among Hepatitis C-Infected Patients Who Inject Drugs in Tbilisi, Georgia

Assessment of HIV Knowledge, Attitude and Behaviour among Hepatitis C-Infected Patients Who Inject Drugs in Tbilisi, Georgia Human Journals Research Article February 2018 Vol.:8, Issue:4 All rights are reserved by Gogia M. et al. Assessment of HIV Knowledge, Attitude and Behaviour among Hepatitis C-Infected Patients Who Inject

More information

Drug Consumption Rooms Worldwide

Drug Consumption Rooms Worldwide Drug Consumption Rooms Worldwide Eberhard Schatz Correlation Network International Network of Drug Consumption Rooms Introduction Overview of the current state of DCR s worldwide Presentation of the INDCR

More information

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS)

Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Results from the NPSinEurope.eu Project 5-Country RAR of New Psychoactive Drugs (NPS) Grund, Jean-Paul Vavrinčíková, Lenka Janíková, Barbara Fidesová, Hana Health responses to NPS EMCDDA, Lisboa. 28-10-2015

More information

FLORIDA S NO WRONG DOOR (NWD) SYSTEM PLANNING PROJECT

FLORIDA S NO WRONG DOOR (NWD) SYSTEM PLANNING PROJECT FLORIDA S NO WRONG DOOR (NWD) SYSTEM PLANNING PROJECT Agenda No Wrong Door (NWD) Planning Project Update Agencies Inventory Stakeholder Survey Planning and Service Area (PSA) Visits NWD System State Plan

More information

Get Hip to Hep: Partnerships for Prevention

Get Hip to Hep: Partnerships for Prevention Get Hip to Hep: Partnerships for Prevention California Immunization Coalition Summit, Sacramento, May 3, 2010 Overview 1. Introduce the California Adult Viral Hepatitis Prevention Strategic Plan 2. Highlight

More information

Table Of Content. Outputs... 8

Table Of Content. Outputs... 8 Table Of Content Operational knowledge to improve HIV early diagnosis and treatment among vulnerable groups in Europe... 2 Summary... 3 Coordinator, Leader contact and partners... 5 Društvo Kulturno, informacijsko

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

HIV testing in Europe: From policy to effectiveness

HIV testing in Europe: From policy to effectiveness HIV testing in Europe: From policy to effectiveness 10 th Think Tank meeting Brussels, 9-10 April 2008 Françoise Hamers Scientific Advice Unit, ECDC ecdc.europa.eu Background About 30% of people living

More information

Government of Canada Federal AIDS Initiative Milestones

Government of Canada Federal AIDS Initiative Milestones HIV in Canada: Trends and Issues for Advancing Prevention, Care, Treatment and Support Through Knowledge Exchange Michael R Smith, Senior Policy Advisor, Programs and Coordination Division, Centre for

More information

ECDC s role in the fight against HIV/AIDS in Europe

ECDC s role in the fight against HIV/AIDS in Europe European Centre for Disease Prevention and Control ECDC s role in the fight against HIV/AIDS in Europe Marita van de Laar, PhD Program Coordinator HIV/AIDS, STI, hepatitis HIV in Europe, Stockholm, 2 November

More information

Scaling Up: Philly, HCV, and IDU

Scaling Up: Philly, HCV, and IDU Scaling Up: Philly, HCV, and IDU Alex Shirreffs, MPH Viral Hepatitis Prevention Coordinator Philadelphia Department of Public Health Welcome to Illadelphia 5 th largest city & 21 st most populous county

More information

New trends in harm reduction in Europe: progress made challenges ahead

New trends in harm reduction in Europe: progress made challenges ahead New trends in harm reduction in Europe: progress made challenges ahead Dagmar Hedrich, Alessandro Pirona, EMCDDA 2 nd European Harm Reduction Conference, 7-9 May 2014, Basel Session 4: Changes in harm

More information

Co-production at the Recovery College

Co-production at the Recovery College Co-production at the Recovery College Inclusion What are we about? De-stigmatising language Students not service users Prospectus not prescription Graduation not discharge Challenging current practice

More information

COUNTRY TABLE. MONTENEGRO.

COUNTRY TABLE. MONTENEGRO. EPIDEMIOLOGICAL DATA Indicator Data Source of data/additional notes re data Year of estimate Population 620 029 National Census data 2011 Estimated number of people who inject drugs (PWID) 1282 (95%CI

More information

EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS

EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS EMPOWERING CIVIL SOCIETY AND PUBLIC HEALTH SYSTEM TO FIGHT TUBERCULOSIS EPIDEMIC AMONG VULNERABLE GROUPS Cinthia Menel Lemos cinthia.menel-lemos@ec.europa.eu Project Officer Executive Agency for Health

More information

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term

More information

Mental Health Promotion and Prevention. Amanda Jones Project Manager Together For You

Mental Health Promotion and Prevention. Amanda Jones Project Manager Together For You Mental Health Promotion and Prevention Amanda Jones Project Manager Together For You Overview Background to Together For You An ounce of prevention is better than a pound of cure Methods of Evaluation

More information

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT

Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Joint Action on HIV and co-infection prevention and harm reduction HA-REACT Principles and challenges of HA-REACT as an example of multilateral and multisectoral programme Mika Salminen, Ph. D, Research

More information

MARA referral M&E Framework with recommended indicators & sources of data

MARA referral M&E Framework with recommended indicators & sources of data MARA referral M&E Framework with recommended indicators & sources of data Health Goal Aims (1) Reduce infections (HIV, Hep B & C, STI) (2) Increase ART treatment, for MARA boys & girls Recommended Indicators

More information

Mid study Advisory Group Meeting, 14 th February 2011

Mid study Advisory Group Meeting, 14 th February 2011 Work Package 3 ( WP3 ): Tuberculosis related service needs, and accessibility and quality of HIV/TB integrated service provision, among injecting drug users Mid study Advisory Group Meeting, 14 th February

More information

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background

Item 4. Sexual Health and Blood Borne Virus Strategy Strategy for Sexual Health and Blood Borne Viruses. Background Item 4 Strategy for Sexual Health and Blood Borne Viruses Background 1. In August 2011 the Scottish Government launched a joint Sexual Health and Blood Borne Virus Framework. This brought four policy areas

More information

THE PORTUGUESE COMMUNITY SCREENING NETWORK

THE PORTUGUESE COMMUNITY SCREENING NETWORK THE PORTUGUESE COMMUNITY SCREENING NETWORK COBATEST Annual Network Meeting 14 May 2018 Presented by: Name goes here Paula Meireles, on behalf of the Community Screening Network EPIUnit ISPUP FUNDING (from

More information

Services and Support Information Leaflet

Services and Support Information Leaflet Services and Support Information Leaflet Services Free HIV and STI Testing Free HIV and STI testing takes place in HIV Ireland on the second and fourth Wednesdays of every month ( exclusive of holidays

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: ROMANIA Adrian Abagiu* & Andrei Botescu** *Romanian Association Against AIDS (ARAS) and National Institute

More information

Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening

Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening Current Hepatitis B and C Screening Practices for Migrants and Barriers to Screening Amena Ahmad, Ralf Reintjes Hamburg University of Applied Sciences, Germany European Conference on Migrant and Ethnic

More information

Strategies of drug users to avoid infection with hepatitis C

Strategies of drug users to avoid infection with hepatitis C With financial support from the Drug Prevention and Information Programme of the European Union Strategies of drug users to avoid infection with hepatitis C Results from five European countries Dr. Heike

More information

Hepatitis prevention in the context of HIV prevention point work in Latvia

Hepatitis prevention in the context of HIV prevention point work in Latvia Hepatitis prevention in the context of HIV prevention point work in Latvia Līva Grāmatiņa Centre for disease prevention and control of Latvia 9..205. HIV prevention point network in Latvia: History; Location;

More information

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES

COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES COUNTRY REPORT: EPIDEMIOLOGICAL SITUATIONS AND PROJECT ACTIVITIES BIRUTE SEMENAITE, MEDICAL DIVISION OF PRISON DEPARTMENT AT THE MINISTRY OF JUSTICE OF THE REPUBLIC OF LITHUANIA LITHUANIAN PRISONS. BACKGROUND:

More information

Eliminating Viral Hepatitis in Australia: Where are we in 2017?

Eliminating Viral Hepatitis in Australia: Where are we in 2017? This document was prepared by Hepatitis Australia in consultation with a variety of stakeholders working in the areas of hepatitis B and hepatitis C in Australia. This included people involved in primary

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Dagmar Hedrich & Isabelle Giraudon, EMCDDA Bergen, 1 September 2015 OVERDOSEKONFERANSEN 2015 ThINCBergen2015: The

More information

HIV/AIDS Joint Action HA-REACT

HIV/AIDS Joint Action HA-REACT HIV/AIDS Joint Action HA-REACT Matthias Schuppe Policy Officer Health Threats Unit DG Health and Food Safety European Commission Policy Framework on HIV/AIDS in EU and neighbouring countries Commission

More information

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations

Strategies to Reduce Harm and HIV/AIDS Infection among Drug Using Populations cessation of use may be the most effective form of harm reduction but, in reality, many clients do not wish to cease using, or find it too difficult. (Addy & Ritter, 2000, p.1) Introduction Historically,

More information

Combating HIV/AIDS and stigmatisation

Combating HIV/AIDS and stigmatisation Goal and objectives Indicators Sources of verification Programme goal Health of vulnerable people has improved. Programme objective Georgian Red Cross has strengthened capacity to improve health of vulnerable

More information

INTRAVENOUS INJECTING DRUG USE.

INTRAVENOUS INJECTING DRUG USE. Injecting drug users in Europe Towards an educational approach Lucas Wiessing European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon lucas.wiessing@ emcdda.org www.emcdda.org It has been

More information

Monitoring and Evaluation Framework for the Tackling Indigenous Smoking Programme

Monitoring and Evaluation Framework for the Tackling Indigenous Smoking Programme Monitoring and Evaluation Framework for the Tackling Indigenous Smoking Programme 30 June 2016 Introduction... 3 Context the TIS programme... 4 2.1 TIS programme objectives... 5 2.2 The delivery of the

More information

DISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017

DISCLOSURE ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER /06/2017 ESPACE GAIA, FIRST DCR IN PARIS SINCE OCTOBER 2016 First results and perspectives DISCLOSURE DR Elisabeth AVRIL Presentation : Espace GAIA, first DCR in Paris : first results and perspectives Mundipharma,

More information

Baseline Survey Concept Paper

Baseline Survey Concept Paper Securing Rights in the Context of HIV and AIDS Program (SRP) July 2013 December 2016 Baseline Survey Concept Paper Ottawa: Jim MacKinnon Manager, Program Development Unit jimmac@oxfam.ca Harare: Roselyn

More information

Towards Integrated Syndromic Surveillance in Europe?

Towards Integrated Syndromic Surveillance in Europe? Towards Integrated Syndromic Surveillance in Europe? Duncan Cooper - Born in Bradford Research Study, UK Triple-S partners including Anette Hulth, Alexandra Ziemann, Jean-Babtiste Perrin, Mark Kanieff,

More information

Viral Hepatitis in the U.S.: Federal Partner Update

Viral Hepatitis in the U.S.: Federal Partner Update Viral Hepatitis in the U.S.: Federal Partner Update Corinna Dan, RN, M.P.H. Office of HIV/AIDS and Infectious Disease Policy October 20, 2015 1 Institute of Medicine Report, 2010 Hepatitis and Liver Cancer:

More information

7th International Symposium on Hepatitis Care in Substance Users

7th International Symposium on Hepatitis Care in Substance Users 7th International Symposium on Hepatitis Care in Substance Users The Abstract Guidelines must be followed as closely as possible in order for your presentation to be considered. Please ensure that the

More information

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015

The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap

More information

The epidemiology of HIV infection in Greece HIV/AIDS reporting system

The epidemiology of HIV infection in Greece HIV/AIDS reporting system HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention

More information

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan

OF THE REPUBLIC OF ARMENIA DECREE. 316 of 1 April 2002 Yerevan Ratified President of the Republic of Armenia R. Kocharyan 1 April 2002 GOVERNMENT OF THE REPUBLIC OF ARMENIA DECREE 316 of 1 April 2002 Yerevan On ratification of the National Programme on HIV/AIDS Prevention

More information

HA-REACT Joint Action on HIV and coinfection. prevention and harm reduction

HA-REACT Joint Action on HIV and coinfection. prevention and harm reduction HA-REACT Joint Action on HIV and coinfection prevention and harm reduction 3 rd EU Health Programme Call: HP-JA-2014, Topic: JA-02-2014 9.4.2015 Mika Salminen/Outi Karvonen 1 A proposal for a Joint Action

More information

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative

Improving NSP and Harm Reduction Services. Jason Farrell, European HCV and Drug Use Initiative Improving NSP and Harm Reduction Services Jason Farrell, European HCV and Drug Use Initiative Presentation Overview With the growing need to treat HCV, NSP programs have been identified in numerous stakeholder

More information

Cambridge Health Alliance (CHA): HCV Treatment Readiness. SPNS grantee meeting March 20, 2013

Cambridge Health Alliance (CHA): HCV Treatment Readiness. SPNS grantee meeting March 20, 2013 Cambridge Health Alliance (CHA): HCV Treatment Readiness SPNS grantee meeting March 20, 2013 Cambridge Health Alliance Zinberg Clinic: Comprehensive primary and specialty care services ~300 HIV+ patients,

More information

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson

Integrating hepatitis C treatment in a regional setting The Cairns Experience. DANA 2018 Morag Goodinson Integrating hepatitis C treatment in a regional setting The Cairns Experience DANA 2018 Morag Goodinson I would like to acknowledge the Traditional Owners of the land, and pay respect to Elders past, present

More information

Integration of services for HIV/AIDS and sexual and reproductive health

Integration of services for HIV/AIDS and sexual and reproductive health January 2012 Integration of services for HIV/AIDS and sexual and reproductive health Pilot projects in India have paved the way for wider use of effective models, strategies, and tools A9, Qutab Institutional

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

Building a New Approach to Health Care Services for Hard to Reach Clients

Building a New Approach to Health Care Services for Hard to Reach Clients Building a New Approach to Health Care Services for Hard to Reach Clients Community Discussion and Open House January 30, 2013 Fernwood Community Association 1923 Fernwood Street February 6, 2013 North

More information

Action Plan on HIV/AIDS in the EU and neighbouring countries:

Action Plan on HIV/AIDS in the EU and neighbouring countries: Action Plan on HIV/AIDS in the EU and neighbouring countries: 2014-2016 Matthias Schuppe Policy Officer Health Threats Unit DG Health and Consumers European Commission Outline o EU policy framework on

More information

Persons with Disabilities: A Neglected Group in HIV and Sexual & Reproductive Health Programming

Persons with Disabilities: A Neglected Group in HIV and Sexual & Reproductive Health Programming Persons with Disabilities: A Neglected Group in HIV and Sexual & Reproductive Health Programming Dr. Waimar Tun, HIVCore/Population Council 5 December 2013 Background and rationale Persons with disabilities

More information

Health Programme support to the European Action Plan HIV/AIDS

Health Programme support to the European Action Plan HIV/AIDS Health Programme 2008-2013 support to the European Action Plan HIV/AIDS 2009-2012 Executive Agency for Health and Consumers EAHC Cinthia Menel Lemos Cinthia.menel-lemos@ec.europa.eu What are the news?

More information

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres

HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres HIV/AIDS IN EASTERN EUROPE AND CENTRAL ASIA (EECA) Charles Ssonko HIV/TB/Hepatitis Adviser Medecins Sans Frontieres Objectives The Epidemiology of HIV/AIDS in the EECA Region (Trends) o The Burden of HIV/AIDS

More information

World Health Organization. A Sustainable Health Sector

World Health Organization. A Sustainable Health Sector World Health Organization A Sustainable Health Sector Response to HIV Global Health Sector Strategy for HIV/AIDS 2011-2015 (DRAFT OUTLINE FOR CONSULTATION) Version 2.1 15 July 2010 15 July 2010 1 GLOBAL

More information

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX

ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) ( ) IMPLEMENTATION MATRIX ANNEX AU PLAN OF ACTION ON DRUG CONTROL AND CRIME PREVENTION (AUPA) (2013-2017) IMPLEMENTATION MATRIX Outcomes and Outputs Performance Indicators Means of Verification Assumptions/Risks Goal: Improve the

More information

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario

Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Ontario Harm Reduction Conference April 30 to May 2, 2017 Toronto, Ontario Views expressed in the attached document do not necessarily represent those of the Ministry of Health and Long Term Care or those

More information

Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006

Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006 Committee of Senior Representatives Tenth Meeting Oslo, Norway 11 December 2006 Reference CSR 10/7.1/1 Title Proposed Terms of Reference for the EG on HIV/AIDS Submitted by Secretariat Summary / Note As

More information

Needle and Syringe Programs - 17 October 2013

Needle and Syringe Programs - 17 October 2013 Needle and Syringe Programs - 17 October 2013 ANCD Position Paper: Needle and Syringe Programs MEDIA RELEASE 17 October 2013 The Australian National Council on Drugs (ANCD) has today released a position

More information

Groups of young people in Uganda that need to be targeted with HIV interventions

Groups of young people in Uganda that need to be targeted with HIV interventions Module 5: HIV/AIDS and young people - Adolescent health and development with a particular focus on sexual and reproductive health - Assignment Peter James Ibembe Reproductive Health Uganda, Kampala, Uganda

More information

Humanitarian Responses: Women, Girls and Gender Equity

Humanitarian Responses: Women, Girls and Gender Equity Humanitarian Responses: Women, Girls and Gender Equity GENDER EQUALITY KNOWLEDGE NOTE Last updated: 19 August 2015 Knowledge Note: Purpose and Application Purpose This Knowledge Note aims to increase the

More information

Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections

Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections Consultation on the Draft National Strategies for Blood Borne Viruses and Sexually Transmissible Infections AFAO comments on draft Third National Sexually Transmissible Infections Strategy 2014 2017 AFAO

More information

Summary Report EU Health Award 2017

Summary Report EU Health Award 2017 EPSA Vaccination Awareness Public Health Campaign 2016 Summary Report EU Health Award 2017 1. Introduction & Case Situation Background With WHO European Vaccine Action Plan 2015-2020 being developed and

More information

Hepatitis C treatment program improves access to housing, income and healthcare

Hepatitis C treatment program improves access to housing, income and healthcare CATIE-News CATIE s bite-sized HIV and hepatitis C news bulletins. Hepatitis C treatment program improves access to housing, income and healthcare 13 July 2015 Despite high rates of hepatitis C virus (HCV)

More information

Improving access of migrant populations to HIV Services in the Caribbean 09/ /2013

Improving access of migrant populations to HIV Services in the Caribbean 09/ /2013 Improving access of migrant populations to HIV Services in the Caribbean 09/2010 02/2013 A PANCAP project assisted by the German Government via the German Agency for Technical Cooperation (GTZ), implemented

More information

DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL)

DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL) DRUG DIVERSION STUDY TOUR ANNIE MADDEN EXECUTIVE OFFICER AUSTRALIAN INJECTING AND ILLICIT DRUG USERS LEAGUE (AIVL) Overview Who is AIVL? Drug User Networks globally Nothing about us without us why is MIPUD

More information

Impact of an SMS- Augmented Participatory Radio Campaign (PRC) in Atanga Sub-County of Northern Uganda

Impact of an SMS- Augmented Participatory Radio Campaign (PRC) in Atanga Sub-County of Northern Uganda Nokoko Institute of African Studies Carleton University (Ottawa, Canada) 2013 (3) Impact of an SMS- Augmented Participatory Radio Campaign (PRC) in Atanga Sub-County of Northern Uganda Naomi Ayot Oyaro

More information

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019

3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 3 rd EACS Standard of care for HIV and co-infections, Bucharest, 2019 Cristiana Oprea MD, Ph.D Associate Professor Carol Davila University of Medicine and Pharmacy Victor Babes Clinical Hospital for Infectious

More information

The National Hepatitis C Plan - Scotland

The National Hepatitis C Plan - Scotland The National Hepatitis C Plan - Scotland Dr Nicola Rowan Scottish Government Dr John Dillon NHS Tayside University of Dundee Policy Introduction Hepatitis C Action Plan for Scotland Phase I: 2006-2008

More information

epidemic among vulnerable groups

epidemic among vulnerable groups Project TUBIDU Empowering public health system and civil society to fight tuberculosis epidemic among vulnerable groups Prepared by: Aljona Kurbatova, NIHD Maarja Sukles, NIHD Liga Rusmane, LTBF What is

More information

ECDC and Spanish Ministry of Health workshop:

ECDC and Spanish Ministry of Health workshop: ECDC and Spanish Ministry of Health workshop: Improving the monitoring of HIV among migrant populations in Europe, Madrid, 3-4 October 2013 Teymur Noori EU Commission Thank Tank on HIV/AIDS Luxembourg,

More information

Tuukka Tammi Drug User Organisations in the Nordic Countries What Do They Want?

Tuukka Tammi Drug User Organisations in the Nordic Countries What Do They Want? Tuukka Tammi Drug User Organisations in the Nordic Countries What Do They Want? Drug User Organisations in the Nordic Countries What Do They Want? Tuukka Tammi tutkimuspäällikkö/research Manager A-klinikkasäätiö/A-Clinic

More information

Rolling up HCV treatment programs for PWIDs in Ukraine

Rolling up HCV treatment programs for PWIDs in Ukraine Rolling up HCV treatment programs for PWIDs in Ukraine www.aph.or g.ua Ludmila Maistat Alliance for Public Health VHPB Meeting, Highlight undeserved groups for screening, prevention and treatment of viral

More information

Barriers to Successful Implementation of Priority Population Programming: Lessons Learned from the Health Smiles Program in Brant County

Barriers to Successful Implementation of Priority Population Programming: Lessons Learned from the Health Smiles Program in Brant County of Priority Population Programming: Lessons Learned from the Health Smiles Program in Brant County Sinton, J. & Vamos, C. Background Ontario s Poverty Reduction Strategy Background Financing of dental

More information

WHAT ARE DECISION MAKERS BARRIERS, FACILITATORS AND EVIDENCE NEEDS REGARDING PEER SUPPORT WORKING? EXECUTIVE SUMMARY

WHAT ARE DECISION MAKERS BARRIERS, FACILITATORS AND EVIDENCE NEEDS REGARDING PEER SUPPORT WORKING? EXECUTIVE SUMMARY WHAT ARE DECISION MAKERS BARRIERS, FACILITATORS AND EVIDENCE NEEDS REGARDING PEER SUPPORT WORKING? EXECUTIVE SUMMARY A report commissioned by the Scottish Recovery Network Jacki Gordon [Jacki Gordon +

More information

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge

HARM REDUCTION & THE OPIOID EPIDEMIC. CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge HARM REDUCTION & THE OPIOID EPIDEMIC CHELSEA RAINWATER Co-Founder & Executive Director No Overdose Baton Rouge NO OVERDOSE BATON ROUGE Formed in late 2013 Community education Naloxone distribution Syringe

More information

Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference

Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference Using Rapid Assessment and Response Methodology: Waterloo Region's Experience Ontario Harm Reduction Distribution Program Conference February 12, 2013 Before we begin Who has completed, or been involved

More information

As a result of this training, participants will be able to:

As a result of this training, participants will be able to: Addressing Sexual Risk with Drug Users and their Partners 1 Day Training This one-day training will build participant knowledge and skills in offering sexual harm reduction options to substance users.

More information

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008

Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe. Lucca, Italy March 2008 Prevention and control of viral hepatitis: the role and impact of patient and advocacy groups in and outside Europe Lucca, Italy 13-14 March 2008 Objectives Review activities, role, rationale and impact

More information

Harms and harm reduction workbook. Country X

Harms and harm reduction workbook. Country X Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious

More information

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC

The Comprehensive Package: The simple truth about our response to drug related HIV. Dr. Monica Beg, Signe Rotberga UNODC The Comprehensive Package: The simple truth about our response to drug related HIV Dr. Monica Beg, Signe Rotberga UNODC HIV among injecting drug users Why is it so important? 30% global HIV infections

More information

Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014

Regional Program Harm Reduction Works Fund It! Baseline assessment. Country: Georgia. Preliminary analysis. 10 October 2014 Regional Program Harm Reduction Works Fund It! Baseline assessment Country: Georgia Preliminary analysis 10 October 2014 Main constraints The formation of representative bodies, such is CCM, is not transparent.

More information

Viral Hepatitis Burden and Policy Directions in the European Region of WHO

Viral Hepatitis Burden and Policy Directions in the European Region of WHO Viral Hepatitis Burden and Policy Directions in the European Region of WHO Dr Nedret Emiroglu WHO Regional Office for Europe Brussels 14-15 October 2010 Global Burden of Chronic Viral Hepatitis 2.7% all

More information

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas

New EU Health Programme: funding mechanisms for civil society working on HIV and related areas New EU Health Programme: funding mechanisms for civil society working on HIV and related areas Cinthia Menel Lemos Think Tank meeting Luxembourg, 10 December 2013 Executive Agency for Health and Consumers

More information

Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015

Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015 Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) Professor Andrew Lloyd Wednesday 7 th October 2015 Australian prison population 30,775 5% 34 92% Total population Increase from 2012 Median

More information

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES

PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More

More information

Participant Autonomy and HCV Elimination:

Participant Autonomy and HCV Elimination: Participant Autonomy and HCV Elimination: End Hep C SF s Community Engagement Model KATIE BURK, MPH VIRAL HEPATITIS COORDINATOR SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH 1 Presentation Objectives 1. Review

More information